NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) reported today that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied permission for an immediate interlocutory appeal, thereby allowing Enzo’s patent infringement lawsuit in Connecticut Federal District Court to go forward against Applera Corp. (NYSE: ABI) and Tropix, Inc.
